Charles Schwab’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$79.3M Buy
170,358
+6,354
+4% +$2.67M 0.01% 928
2026
Q1
$62M Buy
164,004
+14,029
+9% +$6.01M 0.01% 1011
2025
Q4
$64.2M Buy
149,975
+812
+0.5% +$353K 0.01% 990
2025
Q3
$66.8M Buy
149,163
+4,474
+3% +$2.03M 0.01% 964
2025
Q2
$70.5M Sell
144,689
-4,231
-3% -$2.41M 0.01% 874
2025
Q1
$91.6M Buy
148,920
+12,738
+9% +$7.24M 0.02% 689
2024
Q4
$72.1M Buy
136,182
+13,394
+11% +$7.55M 0.01% 852
2024
Q3
$73.8M Buy
122,788
+9,178
+8% +$5.2M 0.01% 838
2024
Q2
$61.6M Buy
113,610
+10,885
+11% +$6.23M 0.01% 914
2024
Q1
$65.9M Buy
102,725
+2,121
+2% +$1.29M 0.02% 836
2023
Q4
$58.8M Buy
100,604
+3,269
+3% +$1.83M 0.01% 859
2023
Q3
$50.6M Buy
97,335
+1,283
+1% +$667K 0.01% 874
2023
Q2
$52M Buy
96,052
+1,295
+1% +$708K 0.01% 837
2023
Q1
$51M Sell
94,757
-27,819
-23% -$14.2M 0.02% 814
2022
Q4
$62.6M Buy
122,576
+4,092
+3% +$1.99M 0.02% 674
2022
Q3
$51.7M Buy
118,484
+1,550
+1% +$745K 0.02% 733
2022
Q2
$54.9M Buy
116,934
+763
+0.7% +$372K 0.02% 694
2022
Q1
$58.8M Buy
116,171
+3,330
+3% +$1.6M 0.02% 766
2021
Q4
$59.7M Sell
112,841
-2,189
-2% -$1.05M 0.02% 785
2021
Q3
$53.5M Buy
115,030
+5,027
+5% +$2.37M 0.02% 818
2021
Q2
$52.2M Buy
110,003
+3,532
+3% +$1.7M 0.02% 838
2021
Q1
$49M Buy
106,471
+2,486
+2% +$1.22M 0.02% 844
2020
Q4
$55.4M Sell
103,985
-3,708
-3% -$1.82M 0.02% 717
2020
Q3
$51.7M Buy
107,693
+4,009
+4% +$1.97M 0.02% 651
2020
Q2
$46.8M Sell
103,684
-5,036
-5% -$2.25M 0.02% 648
2020
Q1
$47.1M Buy
108,720
+828
+0.8% +$370K 0.03% 551
2019
Q4
$47.4M Buy
107,892
+5,904
+6% +$2.48M 0.03% 664
2019
Q3
$42.6M Sell
101,988
-24,031
-19% -$9.81M 0.03% 672
2019
Q2
$45.5M Sell
126,019
-223
-0.2% -$74.5K 0.03% 614
2019
Q1
$40.4M Buy
126,242
+7,600
+6% +$2.33M 0.03% 659
2018
Q4
$33.6M Sell
118,642
-4,341
-4% -$1.31M 0.03% 637
2018
Q3
$39.3M Buy
122,983
+30,168
+33% +$9.61M 0.03% 657
2018
Q2
$29.9M Sell
92,815
-23,978
-21% -$7.5M 0.02% 792
2018
Q1
$31.9M Buy
116,793
+7,659
+7% +$2.03M 0.02% 703
2017
Q4
$26.5M Buy
109,134
+1,717
+2% +$390K 0.02% 786
2017
Q3
$21.7M Buy
107,417
+2,339
+2% +$460K 0.02% 863
2017
Q2
$21.5M Buy
105,078
+387
+0.4% +$77.1K 0.02% 806
2017
Q1
$19.1M Buy
104,691
+8,121
+8% +$1.42M 0.02% 857
2016
Q4
$15.5M Buy
96,570
+5,958
+7% +$875K 0.02% 926
2016
Q3
$12.8M Buy
90,612
+5,267
+6% +$733K 0.02% 983
2016
Q2
$11.6M Buy
85,345
+2,799
+3% +$371K 0.01% 976
2016
Q1
$11.2M Buy
82,546
+2,313
+3% +$313K 0.01% 972
2015
Q4
$12M Buy
80,233
+1,292
+2% +$191K 0.02% 901
2015
Q3
$10.5M Sell
78,941
-1,150
-1% -$161K 0.02% 956
2015
Q2
$10.5M Buy
80,091
+3,240
+4% +$401K 0.01% 991
2015
Q1
$9.18M Buy
76,851
+6,692
+10% +$743K 0.01% 1054
2014
Q4
$7.41M Sell
70,159
-1,814
-3% -$192K 0.01% 1118
2014
Q3
$7.41M Buy
71,973
+996
+1% +$101K 0.01% 1036
2014
Q2
$6.65M Sell
70,977
-340
-0.5% -$30.1K 0.01% 1163
2014
Q1
$6.38M Buy
71,317
+7,396
+12% +$603K 0.01% 1136
2013
Q4
$4.9M Buy
63,921
+725
+1% +$53.5K 0.01% 1271
2013
Q3
$4.55M Sell
63,196
-8,702
-12% -$619K 0.01% 1250
2013
Q2
$5.26M Buy
+71,898
New +$5.27M 0.01% 1002

Other funds holding CHE

Charles Schwab's CHE Position: Q2 2026 in Review

Charles Schwab increased its Chemed (CHE) stake by 3.9% in Q2 2026, buying an estimated $2.67M and bringing the position to 170,358 shares worth $79.3M. The position accounts for 0.01% of the portfolio, ranked #928.

Charles Schwab first reported a position in CHE in Q2 2013 and has held it in 53 quarters since. The position peaked at $91.6M in Q1 2025. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Charles Schwab held 170,358 shares of Chemed worth $79.3M as of Q2 2026.
  • Charles Schwab bought 6,354 Chemed shares in Q2 2026, an estimated $2.67M.
  • Chemed made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #928 holding.
  • Charles Schwab first reported a position in Chemed in Q2 2013 and has held it in 53 quarters since.
  • Charles Schwab's Chemed position peaked at $91.6M in Q1 2025.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.